Henry Schein Stock - Analyst consensus and Q1 beat frame the outlook
17.06.2026 - 20:10:45 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 20:06 CET. Details in the imprint.
Henry Schein (US42548G1040) reported stronger-than-expected first-quarter results in early May, with earnings and revenue modestly ahead of Wall Street forecasts according to an update cited by MarketBeat. The same source now points to a broadly neutral analyst stance with an average "Hold" rating and a consensus target below $90.
All news and data on Henry Schein stock
From earnings headlines to analyst target moves, our Henry Schein hub bundles the latest figures and background on the healthcare distributor.
What recent reports highlight
According to a MarketBeat summary of the latest quarterly release, Henry Schein earned $1.32 per share in Q1 on revenue of $3.37 billion, both slightly above consensus estimates at the time. That beat underscores resilient demand across dental and medical supplies despite a mixed macro backdrop.
The same report notes that several research firms have updated their views in recent months, leaving the stock with an average rating described as "Hold" and a consensus price target of about $87.85. Against a single-digit billion-dollar market capitalization, this implies only moderate upside in the current broker models.
Analyst stance and consensus trends
On this analyst-and-consensus-focused Tuesday, the key message is that Wall Street sees Henry Schein as a steady rather than high-growth story. MarketBeat data show a blend of Buy, Hold and Sell recommendations that nets out to a neutral stance overall.
Such distributions usually reflect balanced risk-reward: near-term earnings supported by recurring demand from dentists and physicians, but limited multiple expansion expectations. For investors tracking healthcare distributors, the consensus target also serves as a rough sentiment gauge after the recent Q1 beat.
How Henry Schein makes its money
Henry Schein generates most of its revenue by distributing dental and medical products and related services to practices and clinics worldwide. Its portfolio ranges from everyday consumables and equipment to digital practice-management solutions that help customers run their businesses more efficiently.
Where the stock trades today
Henry Schein shares (US42548G1040) trade on the Nasdaq at $76.20 as of 06/17/2026, 18:00 CET.
Key facts on Henry Schein stock
- Company: Henry Schein, Inc.
- ISIN: US42548G1040
- WKN: 897961
- Ticker: HSIC
- Venue: Nasdaq
- Price (as of 06/17/2026, 18:00 CET): 76.20 USD
- Market cap: 9.25 billion USD (as of 06/2026)
- Sector / Industry: Health Care - Health Care Supplies & Distribution
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
